SCHEMBL3790199

SCHEMBL3790199

NC(=O)c1cccc(C(N)=O)c1B(O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
METAP2 P50579 1/20 0.45
GAA P10253 1/20 0.44
BCAT2 O15382 1/20 0.43
PARP1 P09874 9/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
PDPK1 O15530 1/20 0.42
AURKA O14965 2/20 0.40
PLK4 O00444 1/20 0.40
CHEK1 O14757 1/20 0.40
DAPK3 O43293 1/20 0.40
MAP4K4 O95819 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL31026556 0.77 ALDH1A1 (0.61) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL3784007 0.76 THRB (0.39) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL29468958 0.74 KDM4E (0.52) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL54119 0.74 KDM4E (0.52) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL3787789 0.74 BCAT2 (0.42) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL27700719 0.73 ALDH1A1 (0.70) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL4967588 0.73 ALDH1A1 (0.70) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL39118 0.73 ALDH1A1 (0.70) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL29956608 0.73 PARP1 (0.41) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL6135290 0.72 ATM (0.61) KDM4EALDH1A1MAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KDM4E 2606/4885ALDH1A1 4339/4885MAPT 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.